Alterola Biotech is trading at 0.004 as of the 22nd of November 2024. This is a 2.44 percent decrease since the beginning of the trading day. The stock's open price was 0.0041. Alterola Biotech has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Alterola Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. The company has 807.05 M outstanding shares. More on Alterola Biotech
Alterola Biotech [ABTI] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alterola Biotech's market, we take the total number of its shares issued and multiply it by Alterola Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alterola Biotech conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 807.05 M outstanding shares.
Alterola Biotech currently holds about 61.54 K in cash with 44.34 K of positive cash flow from operations.
Check Alterola Biotech Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Alterola Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Dashboard Now
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.